Interleukin-1β responses to Mycoplasma pneumoniae infection are cell-type specific

Microbial Pathogenesis

Volumn 34, Issue 1, 2003, Pages 17-25

  Yang, Jun ^a,c   Craig Hooper, W ^b   Phillips, Donald J ^b   Talkington, Deborah F ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Caspase 1; Caspase 1 inhibitor; Cytokine; Interleukin 1 ; Mycoplasma pneumoniae

Indexed keywords

CYCLOHEXIMIDE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; INTERLEUKIN 1; PROTEIN SYNTHESIS INHIBITOR; TUMOR PROTEIN;

ARTICLE; BACTERIUM ADHERENCE; CELL SPECIFICITY; CELL STRAIN; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INACTIVATION; EXTRACELLULAR SPACE; HOST CELL; HUMAN; HUMAN CELL; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; TARGET CELL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CARCINOMA; CELL CULTURE; CELL STRAIN U937; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOPLASMA; MYCOPLASMA PNEUMONIAE; UNCULTURED ACTINOMYCETE;

BACTERIAL ADHESION; CARCINOMA; CASPASE 1; CYCLOHEXIMIDE; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; LUNG NEOPLASMS; MYCOPLASMA PNEUMONIAE; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0037217239     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(02)00190-0     Document Type: Article

References (53)

1. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
2. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol. 16:1998;457-499.
3. Kumar S., McDonnell P.C., Lehr R., et al. Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem. 275:2000;10308-10314.
4. Debets R., Timans J.C., Homey B., et al. Two novel IL-1 family members IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol. 167:2001;1440-1446.
5. Lin H., Ho A.S., Haley-Vicente D., et al. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem. 276:2001;20597-20602.
6. Dunn E., Sims J.E., Nicklin M.J., O'Neill L.A. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol. 22:2001;533-536.
7. Sims J.E., Nicklin M.J., Bazan J.F., et al. A new nomenclature for IL-1-family genes. Trends Immunol. 22:2001;536-537.
8. Dinarello C.A. Interleukin-18. Methods. 19:1999;121-132.
9. O'Neill L.A. The Interleukin-1 Receptor/Toll-like Receptor Superfamily: Signal Transduction During Inflammation and Host Defense. Sci STKE. 2000;RE1-RE2.
10. Colotta F., Re F., Muzio M., et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 261:1993;472-475.
11. Sims J.E., Gayle M.A., Slack J.L., et al. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA. 90:1993;6155-6159.
12. Bian Z.M., Elner S.G., Yoshida A., et al. Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells. Exp Eye Res. 73:2001;111-121.
13. Bin W., Aksoy M.O., Yang Y., Kelsen S.G. IL-1beta enhances beta2-adrenergic receptor expression in human airway epithelial cells by activating PKC. Am J Physiol Lung Cell Mol Physiol. 280:2001;L675-L679.
14. Ng D.C., Long C.S., Bogoyevitch M.A. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1(-stimulated delayed signal tranducer and activator of transcription 3 actiavation, atrial natriuretic factor expression, and cardiac myocyte morphology. J Biol Chem. 276:2001;29490-29498.
15. Muzio M., Ni J., Feng P., Dixit V.M. IRAK (Pelle) family member IRAK2 and MyD88 as proximal mediators of IL-1 signaling. Science. 278:1997;1612-1615.
16. Wesche H., Korherr C., Kracht M., et al. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP Kinases). J Biol Chem. 272:1997;7727-7731.
17. Reddy S.A., Huang J.H., Liao W.S. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NF-κB and AP-1 activation. J Biol Chem. 272:1997;29167-29173.
18. Finch A., Davis W., Carter W.G., Saklatvala J. Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7. Biochem J. 353:2001;275-281.
19. Suzuki K., Hino M., Kutsuna H., et al. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1beta. J Immunol. 167:2001;5940-5947.
20. Funakoshi M., Sonoda Y., Taqo K., Tominaga S., Kasahara T. Differential involvement of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase in the IL-1-mediated NF-κB and AP-1 activation. Int Immunopharmacol. 1:2001;595-604.
21. Cao Z., Tanaka M., Regnier C., et al. NF-kappa B activation by tumor necrosis factor and interleukin-1. Cold Spring Harb Symp Quant Biol. 64:1999;473-483.
22. Jiang B., Brecher P., Cohen R.A. Persistent activation of nuclear factor-kappa B by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler Thromb Vasc Biol. 21:2001;1915-1920.
23. Li X., Commane M., Jiang Z., Stark G.R. IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc Natl Acad Sci USA. 98:2001;4461-4465.
24. Hazuda D.J., Strickler J., Simon P., Young P.R. Structure-function mapping of interleukin 1 precursors. Cleavage leads to a conformational change in the mature protein. J Biol Chem. 266:1991;7081-7086.
25. Black R.A., Kronhcim S.R., Cantrell M., et al. Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor. J Biol Chem. 263:1988;9437-9442.
26. Wingren A.G., Bjorkdahl O., Labuda T., et al. Fusion of a signal sequence to the interleukin-1β gene directs the protein from cytoplasmic accumulation to extracellular release. Cell Immunol. 169:1996;226-237.
27. Thornberry N.A., Bull H.G., Calaycay J.R., et al. A novel heterodimeric cystein protease is required for interleukin-1β processing in monocytes. Nature. 356:1992;768-774.
28. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
29. Ayala J.M., Yamin T.T., Egger L.A., et al. IL-1β-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol. 153:1994;2592-2599.
30. Yamin T.-T., Ayala J.M., Miller D.K. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme. J Biol Chem. 271:1996;13273-13282.
31. Garcia-Calvo M., Peterson E.P., Leiting B., et al. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 273:1998;32608-32613.
32. Bump N.J., Hackett M., Hugunin M., et al. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science. 269:1995;1885-1888.
33. Richter B.W., Duckett C.S. The IAP. proteins: caspase inhibitors and beyond. Sci STKE. 44:2000;PE1-PE2.
34. Uren A.G., Coulson E.J., Vaux D.L. Conservation of baculovirus inhibitor of apoptosis repeat proteins (BIRPs) in viruses, nematodes, vertebrates and yeasts. Trends Biochem Sci. 23:1998;159-162.
35. Zhu Q., Salvesen G.S. Viral caspase inhibitors CrmA and p35. Methods Enzymol. 322:2000;143-154.
36. Takeuchi R., Tsutsumi H., Osaki M., et al. Respiratory syncytial virus infection on neonatal monocytes stimulates synthesis of interferon regulatory factor 1 and interleukin-1β IK-1β)-converting enzyme and secretion of IL-1β J Virol. 72:1998;837-840.
37. Horiuchi M., Yamada H., Akishita M., et al. Interferon regulated fators regulate interleukin-1β-coverting enzyme expression and apoptosis in vascular smooth muscle cells. Hypertension. 33:1999;162-166.
38. Malinoff J., McElhaney R.N., Finch L.R., Baseman J.B. Mycoplasmas: Molecular biology and pathogenesis. 1992.
39. Talkington D.F., Waites K.B., Schwartz S.B., Besser R.E. Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis, and epidemiology of human Mycoplasma pneumoniae infections. Scheld W.M., Craig W.A., Hughes J.M. Emerging Infections 5. 2001;57-84 ASM Press, Washington, DC.
40. Opitz O., Pietsch K., Ehlers S., Jacobs E. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cells subsets in aggravating the inflammatory response. Immunobiology. 196:1996-97;575-587.
41. Schaffner E., Opitz O., Pietsch K., et al. Human pathogenic Mycoplasma species induced cytokine gene expression in Epstein-Barr virus (EBV)-positive lymphobalstoid cell lines. Microbial Pathogenesis. 24:1998;257-262.
42. Yang J., Hooper C.W., Phillips D.J., Talkington D.F. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infection and Immunity. 70:2002;3649-3655.
43. Schonbeck U., Herzberg M., Petersen A., et al. Human vascular smooth muscle cells express interleukin-1β-converting enzyme (ICE), but inhibit processing of the interleukin-1β precursor by ICE. J Exp Med. 185:1997;1287-1294.
44. Uchida Y., Shiba H., Komatsuzawa H., et al. Expression of IL-1 beta and IL-8 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans. Cytokine. 14:2001;152-161.
45. Pirhonen J., Sareneva T., Kurimoto M., Julkunen I., Matikainen S. Virus infection activates IL-1β and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol. 162:1999;7322-7329.
46. Schumann R.R., Belka C., Reuter D., et al. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood. 91:1998;577-584.
47. Coulter K.R., Wewers M.D., Lowe M.P., Knoell D.L. Extracellular regulation of interleukin (IL)-1β through lung epithelial cells and defective IL-1 type II receptor expression. Am J Respir Cell Mol Biol. 20:1999;964-975.
48. Levine S.J., Benfield T., Shelhamer J.H. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am J Respir Cell Mol Biol. 15:1996;245-251.
49. Young L.J., Sukhova G.K., Foster D., et al. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1β-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med. 191:2000;1535-1544.
50. Rodwell A.W., Whitcomb R.F. Methods for direct and indirect measurement of mycoplasma growth. Razin S., Tully J.G. Methods in mycoplasmology. 1983;185-196 Academic Press, New York.
51. Gan X., Bonavida B. Preferential induction of TNF-α and IL-1β and inhibition of IL-10 secretion by human peripheral blood monocytes by synthetic Aza-alkyl lysophospholipids. Cell Immunol. 193:1999;125-133.
52. Liechty K.W., Crombleholme T.M., Cass D.I., Martin B., Adzick N.S. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res. 77:1998;80-84.
53. Yang J., Duerksen-Hughes P.J. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis. 19:1998;1117-1125.